Φορτώνει......
NTM drug discovery: status, gaps and the way forward
Incidence of pulmonary diseases caused by non-tuberculous mycobacteria (NTM), relatives of Mycobacterium tuberculosis, is increasing at an alarming rate, surpassing tuberculosis in many countries. Current chemotherapies require long treatment times and the clinical outcomes are often disappointing....
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Drug Discov Today |
|---|---|
| Κύριοι συγγραφείς: | , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
2018
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6078814/ https://ncbi.nlm.nih.gov/pubmed/29635026 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.drudis.2018.04.001 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|